Clinical Trial Update: A Study of Pemafibrate in Patients With Nonalcoholic Fatty Liver Disease (NAFLD) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for pemafibrate in non-alcoholic fatty liver disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• Pemafibrate (pemafibrate)

Snippet

Sponsor: Kowa Company, Ltd. | Conditions: Non-Alcoholic Fatty Liver Disease | Phase 2 | Status: COMPLETED